MCTox specialized in early stage drug development with a focus on regulatory strategy, toxicology, pharmacology, and pharmacokinetics and supports drug development by designing tailored, product- and indication-specific regulatory toxicology programs.The area of expertise encompasses non-clinical regulatory and toxicology with focus on small molecules and biologics as well as advanced therapy medicinal products (ATMPs), including gene and gene-editing therapies.
Siebensterngasse 31/9
1070 Wien
Vienna
Contact: Monika Chabikovsky (Managing Director)
Email: office.mc@toxicology.cc
Website